FIELD: medicine.
SUBSTANCE: treatment of acute destructive pancreatitis is ensured with intramuscular introduction of Deferoxamine within complex therapy. If accessory signs of disease severity are observed, while free haemoglobin concentration is up to 0.4 g/l, the preparation is introduced in daily dosage 500 mg. If basic signs of disease severity are observed with haemoglobin concentration over 0.4 g/l, dosage is 1000 mg a day. Course duration is 5-7 days.
EFFECT: effective disintoxication without by-action, prevention and elimination of microcirculation disorders in the present category of patients.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PHARMACOLOGICAL CORRECTION OF ENDOGENOUS INTOXICATION IN CASE OF ACUTE DESTRUCTIVE PANCREATITIS | 2003 |
|
RU2245718C2 |
| METHOD FOR TREATMENT OF ACUTE DESTRUCTIVE PANCREATITIS | 2005 |
|
RU2296562C2 |
| METHOD FOR PREDICTING RISE RISK, CLINICAL COURSE AND OUTCOME OF ACUTE ALCOHOLIC PANCREATITIS | 2006 |
|
RU2312348C1 |
| TREATING ENDOTOXICOSIS IN PATIENTS WITH DESTRUCTIVE PANCREATITIS | 1999 |
|
RU2199326C2 |
| METHOD FOR PREDICTION OF DEVELOPING ACUTE PANCREATITIS IN RESIDENTS OF THE REPUBLIC OF BASHKORTOSTAN | 2020 |
|
RU2731693C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF NECROTIC PANCREATITIS | 2009 |
|
RU2405458C1 |
| METHOD FOR BODY DETOXICATION | 2001 |
|
RU2203066C2 |
| METHOD OF SELECTION OF OZONE INDIVIDUAL DOSE WITHIN ACUTE PANCREATITIS TREATMENT | 2007 |
|
RU2328295C1 |
| METHOD FOR ESTIMATING IMMUNE DISORDERS SEVERITY DEGREE IN PATIENTS SUFFERING FROM ACUTE SURGICAL DISEASES | 2006 |
|
RU2314531C1 |
| WAY OF LOW-FLOW ULTRAHEMOFILTRATION AT TREATMENT OF PATIENTS WITH PANCREATONECROSIS | 2008 |
|
RU2363498C1 |
